source
- Roche stops two Huntington's disease gene-silencing programs after disappointing trial dataRoche announced it is ending development of two gene‑silencing candidates aimed at Huntington's disease after data failed to meet expectations. The decision follows a recent readout that showed in…
- German Parliament votes to double mandatory drug rebate to 15.5%, sparking industry concernsGerman lawmakers have approved a bill that would raise the mandatory rebate that drug manufacturers must give the government on branded medicines from the current 7% to 15.5%. The increase is inte…